Whalegun
Home

Jazz Pharmaceuticals JAZZ paid Tarplin, Downs & Young $50K for lobbying in Q1 2024 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q1 2024
Stock
Jazz Pharmaceuticals JAZZ
Client
Jazz Pharmaceuticals
Reported
24/04/22

Down 37.5% from last quarter

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/03/01~24/04/30

Jazz Pharmaceuticals's other lobbying reports

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $80K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $490K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/19

Jazz Pharmaceuticals JAZZ paid Tarplin, Downs & Young $50K for lobbying in Q1 2024 · Health Issues, Medicare | Whalegun